Shares of Gilead Sciences Inc. GILD, +1.04% advanced 1.04% to $85.23 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +1.36% rising 1.36% to 4,003.58 and the Dow Jones Industrial Average DJIA, +1.18% rising 1.18% to 34,098.10. This was the stock’s second consecutive day of gains. Gilead Sciences Inc. hit a new 52-week high, surpassing its previous peak of $85.17, which the company achieved on November 21st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, +0.48% rose 0.48% to $176.82, Merck & Co. Inc. MRK, +1.22% rose 1.22% to $106.90, and AbbVie Inc. ABBV, +1.71% rose 1.71% to $159.79. Trading volume (7.3 M) remained 1.1 million below its 50-day average volume of 8.4 M.